Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
Topical Rose Bengal, 0.005%
Psoriasis
Phase II
Completed
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
Dec 16, 2014
―
Control, Ph-10 (Rose Bengal Disodium 0.001%)
Plaque Psoriasis
Phase II
Terminated
Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
Nov 07, 2007
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Provectus Pharmaceuticals (PVCT) have in its pipeline
PVCT is currently developing the following drugs: Topical Rose Bengal, 0.005%, Control, Ph-10 (Rose Bengal Disodium 0.001%). These drug candidates are in various stages of clinical development as the company works toward FDA approval.